Literature DB >> 16489706

Burden of cancer in Serbia.

Hristina Vlajinac1, Sandra Sipetić-Grujicić, Slavenka Janković, Jelena Marinković, Nikola Kocev, Ljiljana Marković-Denić, Vesna Bjegović.   

Abstract

AIM: To provide a comprehensive assessment of burden of selected cancers in Serbia.
METHOD: We calculated disability adjusted life years (DALY)-- the sum of the years of life lost (YLL) from premature mortality and the years lived with disability (YLD)--for cancers of stomach, colon and rectum, lung, breast, and cervical cancer for central Serbia and Vojvodina, Serbia and Montenegro. The obtained values were compared with the corresponding values for European region as estimated by the World Health Organization. The study was conducted between October 2002 and September 2003. The cancer burden was estimated for the year 2000.
RESULTS: Observed cancers were responsible for 133,689 DALYs (73,197 for men and 60,482 for women). There were significantly more losses because of premature death than disease disability (95.2% vs 4.8% in men P<0.001, and 93.2% vs 6.8% in females, P<0.001). The cancer burden was dominated by lung cancer in men and breast cancer in women. The cancer burden was very small before the age of 35.
CONCLUSION: DALYs per 1000 population were higher in Serbia than in the European region for all observed cancers except for stomach cancer. The participation of a burden caused by disability in the total burden of selected cancers was lower in Serbia than in other European countries, with the greatest differences in colorectal, breast, and cervical cancers.

Entities:  

Mesh:

Year:  2006        PMID: 16489706      PMCID: PMC2080367     

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  12 in total

1.  Progress and directions in refining the global burden of disease approach: a response to Williams.

Authors:  C J Murray; A D Lopez
Journal:  Health Econ       Date:  2000-01       Impact factor: 3.046

2.  Calculating the global burden of disease: time for a strategic reappraisal?

Authors:  A Williams
Journal:  Health Econ       Date:  1999-02       Impact factor: 3.046

3.  A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group.

Authors:  J M Melse; M L Essink-Bot; P G Kramers; N Hoeymans
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

4.  Revised regional model life tables at very low levels of mortality.

Authors:  A Coale; G Guo
Journal:  Popul Index       Date:  1989

5.  The breast cancer related burden of morbidity and mortality in six European countries: the European Disability Weights project.

Authors:  Michelle E Kruijshaar; Jan J Barendregt
Journal:  Eur J Public Health       Date:  2004-06       Impact factor: 3.367

6.  Estimating the burden of disease in an English region.

Authors:  C Bowie; S Beck; G Bevan; J Raftery; F Silverton; A Stevens
Journal:  J Public Health Med       Date:  1997-03

7.  Infectious diseases mortality in central Serbia.

Authors:  H D Vlajinac; J M Marinković; N I Kocev; B J Adanja; T D Pekmezović; S B Sipetić; D J Jovanović
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

8.  [Trends in mortality in Serbia, excluding the provinces, 1973-1994].

Authors:  H Vlajinac; J Marinković; N Kocev; B Adanja; S Sipetić; T Pekmezović; V Zivaljević
Journal:  Srp Arh Celok Lek       Date:  2000 Sep-Oct       Impact factor: 0.207

9.  Understanding DALYs (disability-adjusted life years).

Authors:  C J Murray; A K Acharya
Journal:  J Health Econ       Date:  1997-12       Impact factor: 3.883

10.  Mortality trends of malignant tumours of digestive organs in Belgrade, Yugoslavia, 1975-1997.

Authors:  B Adanja; Z Gledovic; T Pekmezovic; H Vlajinac; M Jarebinski; V Zivaljevic; M Pavlovic
Journal:  Dig Liver Dis       Date:  2000 Jun-Jul       Impact factor: 4.088

View more
  4 in total

1.  Burden of disease resulting from chronic mountain sickness among young Chinese male immigrants in Tibet.

Authors:  Tao Pei; Xiaoxiao Li; Fasheng Tao; Haotong Xu; Haiyan You; Linlin Zhou; Yan Liu; Yuqi Gao
Journal:  BMC Public Health       Date:  2012-06-06       Impact factor: 3.295

2.  VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.

Authors:  Yu Xie; Xiaodong Tan; Haiyan Shao; Qing Liu; Jiyu Tou; Yuling Zhang; Qiong Luo; Qunying Xiang
Journal:  BMC Public Health       Date:  2017-01-25       Impact factor: 3.295

3.  Cancer incidence and mortality in Serbia 1999-2009.

Authors:  Jovan Mihajlović; Petros Pechlivanoglou; Marica Miladinov-Mikov; Snežana Zivković; Maarten J Postma
Journal:  BMC Cancer       Date:  2013-01-15       Impact factor: 4.430

4.  Trends of Stomach Cancer in Central Serbia.

Authors:  Miodrag M Stojanovic; Natasa K Rancic; Marija R Andjelkovic Apostolovic; Aleksandra M Ignjatovic; Mirko V Ilic
Journal:  Medicina (Kaunas)       Date:  2021-06-28       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.